Education
About Us
Working with TipRanks
Follow Us
Iterum Therapeutics Plc (ITRM)
NASDAQ:ITRM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -254.00K | $ -1.75M | $ -1.80M | $ -2.10M | $ -161.00K |
| Operating Income | $ -18.70M | $ -47.47M | $ -30.38M | $ -24.54M | $ -32.13M |
| EBITDA | $ -21.73M | $ -34.58M | $ -39.97M | $ -83.20M | $ -36.01M |
| Net Income | $ -24.77M | $ -38.37M | $ -44.43M | $ -91.56M | $ -52.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 24.13M | $ 23.93M | $ 60.80M | $ 81.34M | $ 14.57M |
| Total Assets | $ 44.59M | $ 26.26M | $ 66.83M | $ 91.51M | $ 32.79M |
| Total Debt | $ 45.53M | $ 18.96M | $ 30.10M | $ 30.43M | $ 48.08M |
| Net Debt | $ 21.41M | $ 12.88M | $ 9.01M | $ 2.98M | $ 33.52M |
| Total Liabilities | $ 48.68M | $ 32.66M | $ 38.83M | $ 41.27M | $ 83.35M |
| Stockholders' Equity | $ -4.08M | $ -6.40M | $ 28.00M | $ 50.23M | $ -50.56M |
| Cash Flow | |||||
| Free Cash Flow | $ -26.77M | $ -39.34M | $ -18.54M | $ -15.90M | $ -54.54M |
| Operating Cash Flow | $ -26.77M | $ -39.33M | $ -18.47M | $ -15.84M | $ -54.53M |
| Investing Cash Flow | $ 18.21M | $ 23.34M | $ 13.96M | $ -54.59M | $ -11.00K |
| Financing Cash Flow | $ 26.69M | $ 1.03M | $ -1.82M | $ 83.13M | $ 64.47M |
Iterum Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.